Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Homeobox protein VENTX is a human transcription factor encoded by the VENTX gene, part of the Vent family of homeodomain-containing proteins[1][3][4][5]. It mainly acts as a transcriptional repressor and is involved in mesodermal patterning and hematopoietic stem cell maintenance. VENTX primarily functions in the regulation of proliferation and differentiation of human hematopoietic and immune cells, especially promoting myeloid over lymphoid lineage commitment[2][4]. Aberrant high expression of VENTX has been observed in leukemic stem cell populations in acute myeloid leukemia, where it supports leukemic cell proliferation, while low or absent expression is seen in normal progenitor populations. VENTX also modulates tumor immunity by influencing tumor-associated macrophage polarization, promoting immune-stimulatory (M1-type) differentiation and potentially reversing immune suppression in the tumor microenvironment[2]. The gene is preserved in humans and primates but not found in rodents[2][4]. Multiple pseudogenes and alternative transcripts exist, including on chromosome X, where a transcribed pseudogene can generate a tumor antigen in melanoma patients[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Homeobox protein VENTX (VENTX).